The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Graduate Department, Bengbu Medical College, Bengbu, China.
Genet Test Mol Biomarkers. 2021 Feb;25(2):145-151. doi: 10.1089/gtmb.2020.0098.
To detect mutations in the and genes in four Chinese families with hereditary multiple osteochondromas (HMO). HMO is an autosomal dominant disorder characterized by the overgrowth of multiple cartilage-capped bones in the metaphysis of long bones and flat bones. Polymerase chain reaction-based amplification followed by DNA sequencing of the complete coding sequences of and was performed for four Chinese families with HMO. The mutant allele was found in six patients: three mutations were found in and two in . A novel frameshift mutation, which generates a premature stop codon at codon 586 and causes partial loss of the glycosyltransferase domain, was detected in exon 9 of EXT1 (F579Yfs8). We hypothesize that F579Yfs8 is a pathogenic mutation. Two novel missense mutations (G339S and V545D) were found in . The variant c.1634T>A (V545D) is apparently benign. In addition we found a novel deletion mutation in , c.856_864 del TTCCTCCTG, which results in the deletion of 286Phe, 287Leu, and 288Leu, that is likely pathogenic. Finally, we identified a likely benign variant in exon 13 of . c.2035-41T>C (rs3740878). We found three novel, potentially pathogenic mutations in and , including a novel frameshift mutation. More importantly, our study results have expanded the spectrum of mutations conducive to the genetic diagnosis and counseling of patients with HMO.
为了检测四个中国遗传性多发性骨软骨瘤(HMO)家系中 EXT1 和 EXT2 基因的突变。HMO 是一种常染色体显性遗传疾病,其特征是长骨和扁骨干骺端的多个软骨帽骨过度生长。对四个 HMO 中国家系进行了基于聚合酶链反应的 EXT1 和 EXT2 完整编码序列的 DNA 测序。在 6 名患者中发现了突变等位基因:在 EXT1 中发现了 3 种突变,在 EXT2 中发现了 2 种突变。在 EXT1 外显子 9 中检测到一种新的移码突变,该突变在密码子 586 产生一个提前终止密码子,并导致糖基转移酶结构域部分缺失(F579Yfs8)。我们假设 F579Yfs8 是一种致病性突变。在 EXT2 中发现了 2 种新的错义突变(G339S 和 V545D)。变体 c.1634T>A(V545D)显然是良性的。此外,我们还在 EXT2 中发现了一个新的缺失突变,c.856_864delTTCCTCCTG,导致 286Phe、287Leu 和 288Leu 的缺失,这可能是致病性的。最后,我们在 EXT2 外显子 13 中鉴定出一个可能良性的变体 c.2035-41T>C(rs3740878)。我们在 EXT1 和 EXT2 中发现了三个新的、可能具有致病性的突变,包括一个新的移码突变。更重要的是,我们的研究结果扩大了 EXT1 突变谱,有利于 HMO 患者的遗传诊断和咨询。